Program - Pfizer (Test) 3  

Program - Pfizer (Test) - UATDR & R12.5.3_S03#Program

Program v7.2 _Demo  

Program v7.2 (Do Not Touch)

Test_Basrah  

Embed-Program01  

Trial - Website Test Data (Do not touch)  

Trial - Website Test Data (Do not touch)TodoCreate a Website with 4 PagesCreate a Website with all the blocksUpdate properties of all the blocksUpdate properties of all the blocks with different combinationsUpdate the content present inside the block by formattingUpdate the Global settings of the websiteAdd Custom URLs, image links …

Check Site Phone Validation  

Check Site Phone Validation

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (AIRLYMPUS)

The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, who are not currently eligible for biologic treatments.

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps (CEREN2)

The purpose of the study is to evaluate the efficacy, safety and tolerability of 2 dosing regimens of itepekimab compared to placebo as add-on therapy to intranasal corticosteroids (INCS) in male and female participants with chronic rhinosinusitis with nasal polyps (CRSwNP) aged 18 years of age and older.

Role of Coenzyme Q in ADHD in Children

Role of Coenzyme Q in ADHD in Children

Preschool ADHD On-line Behavioral Treatment

The primary goal of the proposed project is to test the feasibility of parent and teacher/childcare providers use of the ADHD web portal-integrated behavioral treatment modules with preschool children with ADHD in order to improve the access to and the integrity of evidence-based behavioral treatment strategies for young children with …